NEXT Oncology is a clinical research site located in Austin, Texas, United States 78758.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
NEXT Oncology has participated in 22 clinical trials with 13 currently active.
Therapeutic areas: Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer.
Sponsors: Bolt Biotherapeutics, Inc., Kura Oncology, Inc., Chugai Pharmaceutical.
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology has 22 clinical trials on record, with 13 currently active. Their work covers Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer.
NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.